Russia Missile Tests Raise Questions

Global Security Newswire Staff
Add to Briefcase
See more stories about...
Global Security Newswire Staff
Oct. 25, 2013, 1:02 p.m.

The U.S. State De­part­ment is re­fut­ing an as­ser­tion in a Wash­ing­ton Free Beacon re­port that Rus­sia may be in vi­ol­a­tion of the 1987 In­ter­me­di­ate-Range Nuc­le­ar Forces Treaty with its re­cent tests of sev­er­al new bal­list­ic mis­siles.

On Oct. 10, Rus­sia test-fired its SS-25 in­ter­con­tin­ent­al bal­list­ic mis­sile to a dis­tance less than 2,000 miles. Mo­scow de­clared the goal of the tri­al was to de­vel­op a new “com­bat pay­load,” the Beacon re­por­ted.

The Beacon stated the test flight of the long-range in­ter­con­tin­ent­al bal­list­ic mis­sile “ap­pears to be” a cir­cum­ven­tion of the nuc­le­ar-mis­sile ac­cord. Still, in­de­pend­ent is­sue ex­perts and U.S. of­fi­cials in­ter­viewed by the pub­lic­a­tion offered dif­fer­ent views over wheth­er Rus­sia was in vi­ol­a­tion or not.

A State De­part­ment of­fi­cial told the Beacon: “The test of a Rus­si­an RS-12M To­pol ICBM on Oct. 10, which was an­nounced in the Rus­si­an press, was con­duc­ted con­sist­ent with the re­quire­ments of the New START treaty and was not sub­ject to any pro­vi­sions or re­stric­tions un­der the INF Treaty.”

Ac­cord­ing to the Fed­er­a­tion of Amer­ic­an Sci­ent­ists, un­der the INF Treaty Rus­sia and the United States agreed to give up all of their nuc­le­ar-tipped ground-launched cruise and bal­list­ic mis­siles with ranges between 300 and 3,400 miles.

The SS-25 is known as the RS-12M in Rus­sia.

Rus­sia on three oc­ca­sions also has tested its fifth-gen­er­a­tion RS-26 long-range mis­sile to a dis­tance short­er than ICBM-flight cap­ab­il­ity. The road-mo­bile RS-26 is also known as the Yars M.

NOTE: This art­icle was up­dated at 5 p.m. on Fri­day, Oct. 25.

What We're Following See More »
ANOTHER NUCLEAR OPTION?
Byrd Rule Could Trip Up Health Legislation
3 hours ago
THE DETAILS

"Even if House Republicans manage to get enough members of their party on board with the latest version of their health care bill, they will face another battle in the Senate: whether the bill complies with the chamber’s arcane ... Byrd rule, which stipulates all provisions in a reconciliation bill must affect federal spending and revenues in a way that is not merely incidental." Democrats should have the advantage in that fight, "unless the Senate pulls another 'nuclear option.'”

Source:
ONE WEEK
Senate Votes To Fund Government
5 hours ago
BREAKING
ON TO SENATE
House Passes Spending Bill
6 hours ago
BREAKING

The House has passed a one-week spending bill that will avert a government shutdown which was set to begin at midnight. Lawmakers now have an extra week to come to a longer agreement which is expected to fund the government through the end of the fiscal year in September. The legislation now goes to the Senate, where it is expected to pass before President Trump signs it.

FULL CABINET IN PLACE
Acosta Confirmed As Labor Secretary
7 hours ago
THE DETAILS

Alexander Acosta was confirmed Thursday night as Labor secretary, officially filling out President Trump's cabinet on day 98 of his presidency. Nine Democrats joined every present Republican in voting to approve Acosta, with the final tally at 60-38. Trump's first choice for Labor secretary, Andrew Puzder, withdrew his nomination after taking criticism for hiring undocumented workers and for other matters in his personal life.

Source:
HAS WHITE HOUSE BACKING
Hurd to Make Push on Federal IT
8 hours ago
THE DETAILS

"Rep. Will Hurd (R-TX) plans to introduce legislation today designed to help federal agencies update their aging technology—and this time, it has White House backing. Hurd worked alongside White House Office of American Innovation officials Reed Cordish and Chris Liddell in crafting and tweaking the legislation, and called their partnership an 'invaluable' part of the process."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login